Dr. Rohs on Databases of Uncommon Mutations in NSCLC

Nicholas C. Rohs, MD, assistant professor of Medicine, hematology and oncology, Icahn School of Medicine, Mount Sinai, discusses databases of uncommon mutations in non–small cell lung cancer (NSCLC).

It is becoming common practice to see databases built for information on uncommon mutations in NSCLC, Rohs explains. However, many of these databases are constructed by single institutions or community practices, and data are not merged across different centers, Rohs says. Companies and institutions are working to form larger, centrally based datasets, Rohs adds.

The Mount Sinai Hospital is working to compile some of these data to better examine subsets for certain mutations, Rohs continues. Continuing to develop these larger databases will be important for improving access to key information to improve patient care, Rohs concludes.